MDCG issues guidance on safety reporting for device studies under MDR

By Published On: May 15th, 20201.3 min read

MDCG issues guidance on safety reporting for device studies under MDR

By Published On: May 15th, 20201.3 min read

The European Commission’s Medical Device Coordination Group (MDCG) issued a guidance explaining how safety reporting in clinical investigations of medical devices should be performed under the MDR.

The guidance applies to:

  • premarket clinical investigations of non-CE marked devices,
  • premarket clinical investigations  of CE marked devices used outside their intended uses
  • device studies covered under MDR Article 82
  • certain postmarket clinical follow-up investigations, such as those involving procedures outside the normal conditions of use of the device and those imposing additional invasive or burdensome procedures
  • trials initiated under the Active Implantable Medical Devices Directive and the Medical Devices Directive
  • medical devices used in clinical trials for medicinal products, unless the study is not meant to assess the safety or performance of a CE-marked device and the device is used according to its intended purpose.

For more details, please see the guidance from MDCG.

Meditrial can help – Contact us for immediate support

Meditrial has developed rapid workflows to conduct risk assessment, implement rescue plans and execute solutions for ongoing clinical trials:

Contact Meditrial for immediate assistance in Europe or the US.

Free Helpline +1-800-901-4286

helpline@meditrial.net

Table of Contents

Latest Articles

This article provides general information and does not constitute regulatory, legal, clinical, or compliance advice. Requirements and appropriate processes may vary by study, product, jurisdiction, and organization. Medigen Suite functionality should be used in accordance with applicable regulations, study documentation, and internal procedures.

Go to Top